George N Dalekos Selected Research

Autoimmune Hepatitis

4/2022	Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group.
1/2022	Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis.
5/2021	FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseases.
1/2021	First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients.
1/2021	Impact of genetic and environmental factors on autoimmune hepatitis.
1/2021	Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing.
8/2020	Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis.
1/2020	Permanent immunosuppression in SLA/LP-positive autoimmune hepatitis is required although overall response and survival are similar.
10/2019	Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation?
1/2019	Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George N Dalekos Research Topics

Disease

29	Autoimmune Hepatitis 04/2022 - 10/2004
29	Fibrosis (Cirrhosis) 02/2022 - 05/2005
25	Liver Diseases (Liver Disease) 01/2022 - 05/2006
21	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2021 - 05/2006
17	Chronic Hepatitis B 11/2022 - 05/2006
14	Infections 06/2022 - 10/2004
14	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2014
12	Hepatitis 12/2022 - 10/2004
9	Hepatitis B 11/2022 - 11/2006
9	COVID-19 04/2022 - 01/2021
9	Sclerosing Cholangitis 03/2021 - 05/2006
8	Chronic Hepatitis C 01/2020 - 10/2004
6	Liver Cirrhosis (Hepatic Cirrhosis) 02/2022 - 01/2017
6	Hepatitis D 01/2022 - 01/2011
6	Autoimmune Diseases (Autoimmune Disease) 08/2020 - 06/2007
5	Disease Progression 01/2022 - 11/2013
5	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2021 - 10/2004
5	Fever (Fevers) 12/2020 - 07/2009
5	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 10/2004
4	Liver Failure 12/2022 - 07/2013
4	Non-alcoholic Fatty Liver Disease 01/2020 - 03/2010
4	Chronic Hepatitis D 12/2015 - 10/2004
4	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2009 - 05/2005
3	Neoplasms (Cancer) 01/2022 - 05/2011
3	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2021
3	Fatty Liver 01/2021 - 03/2008
3	Obesity 01/2020 - 04/2013
3	Inflammation (Inflammations) 03/2017 - 09/2009
2	Acute Liver Failure (Fulminant Hepatic Failure) 12/2022 - 01/2018
2	Critical Illness (Critically Ill) 04/2022 - 01/2022
2	Leukemia 03/2021 - 06/2008
2	Thrombocytopenia (Thrombopenia) 11/2019 - 05/2006
2	Hepatitis C 01/2017 - 11/2006
2	Leishmaniasis 04/2015 - 07/2009
2	Hematologic Neoplasms (Hematological Malignancy) 07/2013 - 02/2012
2	Celiac Disease (Celiac Sprue) 10/2012 - 04/2008
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2011 - 11/2006
1	Bacteremia 06/2022
1	Iron Overload 06/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2022

Drug/Important Bio-Agent (IBA)

19	AutoantibodiesIBA 12/2022 - 10/2004
15	Immunoglobulin G (IgG)IBA 12/2022 - 05/2005
15	AntibodiesIBA 01/2022 - 11/2006
13	Antiviral Agents (Antivirals)IBA 11/2022 - 01/2012
12	EnzymesIBA 06/2022 - 02/2007
12	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 03/2009
9	InterferonsIBA 04/2022 - 03/2008
9	entecavir FDA Link 01/2022 - 12/2008
8	Hepatitis B e AntigensIBA 11/2022 - 12/2008
8	Tenofovir (Viread)FDA Link 01/2022 - 04/2012
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2009
7	AntigensIBA 11/2022 - 05/2007
6	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022 - 09/2011
6	ImmunosorbentsIBA 06/2022 - 02/2007
6	Transaminases (Aminotransferases)IBA 04/2022 - 07/2009
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2006
6	BilirubinIBA 12/2021 - 07/2015
6	Biomarkers (Surrogate Marker)IBA 05/2021 - 06/2007
5	RNA (Ribonucleic Acid)IBA 11/2022 - 03/2010
5	Pharmaceutical PreparationsIBA 01/2017 - 01/2011
4	Alkaline PhosphataseIBA 02/2022 - 07/2015
4	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 01/2021
4	Cartilage Oligomeric Matrix ProteinIBA 07/2021 - 07/2015
4	adefovirIBA 12/2015 - 01/2011
4	Immunoglobulin A (IgA)IBA 10/2012 - 07/2007
3	Ferritins (Ferritin)IBA 06/2022 - 01/2015
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2022 - 07/2015
3	AlbuminsIBA 02/2022 - 07/2015
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022 - 01/2019
3	Azathioprine (Imuran)FDA LinkGeneric 01/2021 - 09/2011
3	liver antigen LA-1IBA 01/2020 - 02/2007
3	Rituximab (Mabthera)FDA Link 07/2013 - 03/2011
3	Anticardiolipin AntibodiesIBA 09/2008 - 05/2005
2	VaccinesIBA 12/2022 - 01/2022
2	HepcidinsIBA 06/2022 - 01/2015
2	CytokinesIBA 04/2022 - 01/2020
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2022 - 10/2021
2	PlasminogenIBA 10/2021 - 10/2021
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2021 - 10/2021
2	Immunomodulating AgentsIBA 01/2021 - 01/2019
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2019 - 01/2018
2	peginterferon alfa-2a (Pegasys)FDA Link 05/2015 - 01/2011
2	Messenger RNA (mRNA)IBA 01/2015 - 11/2006
2	AdipokinesIBA 05/2014 - 04/2013
2	AdiponectinIBA 05/2014 - 03/2008
2	Lamivudine (Epivir)FDA Link 04/2012 - 12/2008
2	Immunoglobulin M (IgM)IBA 01/2012 - 09/2008
2	AutoantigensIBA 05/2011 - 10/2004
2	Immunoglobulins (Immunoglobulin)IBA 07/2008 - 11/2007
2	LeptinIBA 11/2006 - 05/2006
2	Urea (Carbamide)FDA LinkGeneric 05/2006 - 05/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2022
1	IronIBA 06/2022

Therapy/Procedure

24	Therapeutics 12/2022 - 05/2006
9	Liver Transplantation 12/2022 - 07/2014
6	Aftercare (After-Treatment) 06/2022 - 02/2012
2	Artificial Respiration (Mechanical Ventilation) 04/2022 - 01/2022
2	Duration of Therapy 01/2020 - 09/2009
2	Retreatment 01/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 07/2013 - 02/2012